Tuesday, 17 December 2019

Questions (354)

Alan Kelly


354. Deputy Alan Kelly asked the Minister for Health the way in which the gainshare and incentive model for biosimilar prescribing operates; if €500 per patient is being allocated to hospital treatment areas that prescribe biosimilars is taking place as reported; if the HSE or his Department has estimated the overall savings potential of biosimilar prescribing; and if he will make a statement on the matter. [52711/19]

View answer

Written answers (Question to Health)

The Health Service Executive has operational responsibility for best-value biological medicines, thus the matter has been referred to the HSE for its attention and direct reply to the Deputy.